AKEBIA THERAPEUTICS, INC. Capitalized Computer Software, Amortization
AKEBIA THERAPEUTICS, INC. (AKBA) reported Capitalized Computer Software, Amortization of $100.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareAmortization1 · last filed 2024-11-07
- AKEBIA THERAPEUTICS, INC. capitalized computer software, amortization for the quarter ending 2024-09-30 was $100.00K.
- AKEBIA THERAPEUTICS, INC. capitalized computer software, amortization for the quarter ending 2024-06-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. capitalized computer software, amortization for the quarter ending 2024-03-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. capitalized computer software, amortization for the quarter ending 2023-09-30 was $0.00.
| Period end | Capitalized Computer Software, Amortization 3 month | Capitalized Computer Software, Amortization 6 month | Capitalized Computer Software, Amortization 9 month |
|---|---|---|---|
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-07 | $100.00K derived: sum of 2 quarters · filed 2024-11-07 | $100.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |